NCT03163810View on ClinicalTrials.gov

A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 6, 2017

Primary Completion Date

December 13, 2017

Study Completion Date

December 13, 2017

Conditions
Nonalcoholic Steatohepatitis
Interventions
DEVICE

Erchonia Verju Laser

The Erchonia Verju Laser is applied 2 times a week to the front and back of the waist, hips and upper abdomen for 30 minutes each time over 8 to 12 weeks.

DEVICE

Erchonia EVRL Laser

The Erchonia EVRL Laser is applied under the right ribcage angled towards the liver for 10 minutes, one time per week over the same 8 to 12 weeks as the Verju Laser is administered.

Trial Locations (1)

85250

Meridian Integrative Medicine, Scottsdale

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY

NCT03163810 - A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter